Skip to main content
. 2022 Jan 31;32(1):29–39. doi: 10.1089/nat.2021.0043

FIG. 3.

FIG. 3.

Ambulatory function: (A) 6MWT distance and (B) loss of ambulation over 3 years in golodirsen-treated patients and matched exon 53 skip-amenable natural history external controls. 6MWT, 6-minute walk test.